The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content
| Saunders and Walker

The Food and Drug Administration has strengthened already tough warnings on certain epilepsy drugs that are also used to treat bipolar disorder and nerve pain. In addition, the FDA singled out those of Asian ancestry to undergo genetic testing prior to beginning any regimen with the drug carbamazepine which is distributed as Carbatrol by Shire PLC, Tegretol by Novartis AG and Equetro by Validus Pharmaceuticals Inc. The warnings come as a result of the drugs link with a rare but severe skin reaction which includes itching, rash, toxic epidermal necrolysis and Stevens-Johnson syndrome.

For more information on this subject, please refer to the section on Drugs, medical Devices, and Implants.

Comments are closed.